Blade Air Mobility Q3 revenue up 125% to $45.7M; Flight Profit up 108%

Strata Critical Medical, Inc.

2022-Q3 EPS reported -$0.17 revenue$107,985,000

Revenue $45.7M (+125% YoY); Short Distance up 52%, MediMobility up 801%.
Flight Profit $9.3M (+108%); Flight Margin 20.3% (down from 22.0% YoY due to mix shift).
Net loss $9.2M unchanged; Adjusted EBITDA $(4.5)M improved to (9.9)% of revenue from (15.5)%.
Completed Blade Europe acquisition for $48.1M cash; now largest urban air mobility company across 3 continents.
MediMobility serves 67 transplant centers; pro forma organic revenue growth of 174% versus prior year.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.95

Strata Critical Medical, Inc. reported the third quarter ended September 30, 2022 results: revenue $45.7 million, net income $9.2 million.

Period: the third quarter ended September 30, 2022
Revenue: $45.7 million
Net income: $9.2 million
Result: reported results

Exact text from the filing

Air Mobility Reports Financial Results for the Third Quarter Ended September 30, 2022 • Third quarter ended September 30, 2022 revenue up 125% versus the prior year period to $45.7 million; nine month period ended September 30, 2022 revenue up 154% versus the prior year period to $108.0 million • Short Distance revenue up 52% in Q3 2022 versus the prior year

View on SEC.gov

Browse all earnings releases →

Strata Critical Medical, Inc. filing history →

Source: SEC EDGAR

accession 0001779128-22-000109

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.